$177.83
0.43% yesterday
NYSE, Jun 27, 10:13 pm CET
ISIN
US74834L1008
Symbol
DGX

Quest Diagnostics Stock price

$177.83
+4.15 2.39% 1M
+25.20 16.51% 6M
+26.97 17.88% YTD
+40.49 29.48% 1Y
+39.27 28.34% 3Y
+67.41 61.05% 5Y
+106.64 149.80% 10Y
+124.98 236.48% 20Y
NYSE, Closing price Fri, Jun 27 2025
+0.77 0.43%
ISIN
US74834L1008
Symbol
DGX
Sector

Key metrics

Basic
Market capitalization
$19.9b
Enterprise Value
$25.5b
Net debt
$5.7b
Cash
$188.0m
Shares outstanding
112.0m
Valuation (TTM | estimate)
P/E
22.54 | 18.16
P/S
1.95 | 1.82
EV/Sales
2.51 | 2.34
EV/FCF
24.17
P/B
2.87
Dividends
DPS
$3.00
Yield 1Y | 5Y
1.69% | 1.98%
Growth 1Y | 5Y
5.63% | 7.19%
Payout 1Y | 3Y
39.16% | 36.61%
Increased
14 Years
Financials (TTM | estimate)
Revenue
$10.2b | $10.9b
EBITDA
$1.6b | $2.2b
EBIT
$1.5b
Net Income
$892.0m | $1.1b
Free Cash Flow
$1.1b
Growth (TTM | estimate)
Revenue
9.38% | 10.38%
EBITDA
12.32% | 41.11%
EBIT
11.38%
Net Income
5.94% | 26.67%
Free Cash Flow
11.51%
Margin (TTM | estimate)
Gross
33.15%
EBITDA
15.70% | 19.88%
EBIT
14.35%
Net
8.78% | 10.07%
Free Cash Flow
10.40%
Financial Health
Equity Ratio
41.96%
Return on Equity
12.78%
ROCE
10.16%
ROIC
-
Debt/Equity
0.85
More
EPS
$7.89
FCF per Share
$9.43
Short interest
3.72%
Employees
50.50k
Rev per Employee
$200.00k
Show more

Is Quest Diagnostics a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Quest Diagnostics Stock Analysis

Unlock Scores for Free

Analyst Opinions

24 Analysts have issued a Quest Diagnostics forecast:

13x Buy
54%
11x Hold
46%

Analyst Opinions

24 Analysts have issued a Quest Diagnostics forecast:

Buy
54%
Hold
46%

Financial data from Quest Diagnostics

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
10,158 10,158
9% 9%
100%
- Direct Costs 6,791 6,791
9% 9%
67%
3,367 3,367
10% 10%
33%
- Selling and Administrative Expenses 1,765 1,765
8% 8%
17%
- Research and Development Expense - -
-
-
1,595 1,595
12% 12%
16%
- Depreciation and Amortization 137 137
23% 23%
1%
EBIT (Operating Income) EBIT 1,458 1,458
11% 11%
14%
Net Profit 892 892
6% 6%
9%

In millions USD.

Don't miss a Thing! We will send you all news about Quest Diagnostics directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Quest Diagnostics Stock News

Neutral
PRNewsWire
3 days ago
SECAUCUS, N.J. , June 25, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today published its 2024 Corporate Responsibility Report.
Neutral
PRNewsWire
5 days ago
SECAUCUS, N.J. , June 23, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that it will report second quarter 2025 financial results on Tuesday, July 22, 2025, before the market opens.
Positive
Investors Business Daily
8 days ago
Quest Diagnostics stock is hovering in and around a buy zone. To limit risk, consider using a long call butterfly setup in options.
More Quest Diagnostics News

Company Profile

Quest Diagnostics, Inc. engages in the provision fo diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.

Head office United States
CEO James Davis
Employees 50,500
Founded 1967
Website www.questdiagnostics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today